Hims & Hers Health, Inc. - Class A Common Stock, $0.0001 par value per share (HIMS)

CUSIP: 433000106

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+2,454,016
Put/Call ratio
101%
SEC-reported price per share
$6.55
Indexed holders
137
Value change
+$14,988,392
Number of buys
73
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
223,790,875

Security key

433000106

Report period

Q4 2021

Indexed institutions

137

Top holders

10

Ownership snapshot

Top reported holders of HIMS - Hims & Hers Health, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Jack Abraham
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
14 Dec 2021
3/4/5 13F Highest disclosed value: $80,463,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $80.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
Jack Abraham $69.43M
VANGUARD GROUP INC $80.46M
OAKTREE CAPITAL MANAGEMENT LP $28.45M
Thrive Capital Management, LLC $24.15M
Disruptive Technology Advisers LLC $19.17M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Jack Abraham
3/4/5
10%+ Owner
—
denominator unverified
$69,430,248
7,889,801 shares
— 14 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$80,463,000
10,671,442 shares
— 30 Sep 2021
OAKTREE CAPITAL MANAGEMENT LP
13F
Company
13F
—
denominator unverified
$28,452,000
3,773,437 shares
— 30 Sep 2021
Thrive Capital Management, LLC
13F
Company
13F
—
denominator unverified
$24,148,000
3,202,616 shares
— 30 Sep 2021
Disruptive Technology Advisers LLC
13F
Company
13F
—
denominator unverified
$19,169,000
2,542,418 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$16,225,000
2,151,909 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
137
Shares
70,024,982
Indexed holders
137
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 indexed holders
107
Q4 2021 indexed holders
137
Indexed holder difference
30
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .